Liposome-Immunization Antibody Production Service
Some antigens — lipids, glycolipids, polysaccharides, and nucleic acids — are so weakly immunogenic that even attaching them to a carrier often fails to yield a specific antibody, because the immune system does not take them up and process them efficiently. The bottleneck is delivery: the antigen must reach antigen-presenting cells in a form that provokes a response. Liposomes solve this by carrying the antigen inside a particle the immune system readily engages, turning a substance the body would ignore into one it can respond to.
We prepare these antibodies by using liposomes as the immunization vehicle. Because a liposome's size, surface charge, and membrane composition can be tuned, the same approach adapts to different weak immunogens, and because the liposome itself is inert it is well suited to vaccine-related work where an unwanted adjuvant effect from the carrier must be avoided. We control the particle size through preparation so the antigen is presented in a form the immune system handles well.
What the Service Covers
- Antigen evaluation – assessing why the antigen fails to provoke a response on its own.
- Liposome design – setting particle size, charge, and membrane composition for the target.
- Antigen loading – encapsulating or embedding the weak immunogen in the particle.
- Immunization and screening – raising the response and selecting antibodies against the antigen.
- Validation – confirming the antibody recognizes the free antigen, not just the particle.
Why Liposomes Help
| Property | Benefit for a weak immunogen |
| Particle form | The immune system takes up and processes particulate antigen more readily than free soluble material |
| Tunable size and charge | The particle is adjusted to the antigen and the desired uptake route |
| Adjustable membrane | Composition is changed to improve presentation without altering the antigen |
| Inert carrier | The liposome itself contributes no unwanted biological activity, suiting vaccine-related use |
The Liposome Approach
- Particle design – choose size, charge, and membrane composition for the antigen.
- Antigen loading – encapsulate or embed the target so it travels with the particle.
- Controlled presentation – keep particle dimensions in a range that supports efficient handling by immune cells.
- Screening against the antigen – confirm the antibody binds the free antigen, not only the liposome.
Workflow
- Evaluate the antigen – determine the cause of weak immunogenicity.
- Design the particle – set liposome properties for the target.
- Load and characterize – prepare the loaded particle and confirm its properties.
- Immunize and screen – raise the response and select antigen-specific antibodies.
- Validate and deliver – confirm specificity and supply the antibody with data.
Applications
- Anti-lipid and anti-glycolipid antibodies – reagents against lipid-structured antigens that are otherwise hard to raise.
- Polysaccharide targets – antibodies against sugar antigens presented more effectively as particles.
- Nucleic-acid-targeting antibodies – reagents against DNA or RNA structures used as antigens.
- Vaccine and adjuvant research – where an inert particulate carrier is preferred.
Why Work With Us
When an antigen is ignored rather than rejected, the problem is presentation, and a better carrier alone may not be enough. We use liposomes as an active delivery vehicle — tuning the particle to the antigen and confirming the resulting antibody recognizes the free antigen — so a substance that would otherwise never provoke a response becomes the basis of a specific reagent.
